BIOVIE INC
BIVINASDAQTrading Snapshot
- Day Range
- $1.25 – $1.30
- 52-Week Range
- $0.82 – $2.31
- Volume
- $3.78B
- Avg Volume
- $4.81B
- Shares Outstanding
- 7.5M
- Next Earnings
- Oct 12, 2026
Fundamentals Snapshot
- Annual Revenue
- $684,198
- Last Q Revenue
- $160,543
- P/E Ratio
- -0.5
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-2.64
- Dividend Yield
- 0.00%
Why Investors Own BIVI
- ✓High-growth profile — revenue up -3.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 60% gross margin and 12% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About BIOVIE INC
BioVie Inc. is a clinical-stage biotechnology firm primarily dedicated to the discovery, development, and commercialization of innovative drug treatments across the United States. The company's developmental portfolio includes BIV201, a therapeutic agent that has successfully completed its Phase IIa clinical trial for addressing ascites resulting from chronic liver cirrhosis. Additionally, BioVie is advancing NE3107, which is currently undergoing a Phase III clinical trial for the management of mild to moderate Alzheimer's disease, and is also in a Phase I clinical trial for the treatment of Parkinson's disease. Further preclinical investigations are underway for NE3107, exploring its potential applications in treating multiple myeloma and prostate cancer. Established in 2013, the company adopted its current name, BioVie Inc., in July 2016, having previously operated as NanoAntibiotics, Inc. Its corporate headquarters are situated in Carson City, Nevada.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Which stocks have an unusual volume on Friday?
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
Which stocks are gapping on Friday?
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out yesterday.
Top stock movements in today's session.
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top gainers and losers in today's session.
Let's uncover which stocks are experiencing notable gaps during today's session.
Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps.